|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Aprea Therapeutics (NASDAQ: APRE) through any online brokerage.
The latest price target for Aprea Therapeutics (NASDAQ: APRE) was reported by RBC Capital on 2021-03-17. The analyst firm set a price target for 8.00 expecting APRE to rise to within 12 months (a possible 81.00% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Aprea Therapeutics (NASDAQ: APRE) is $4.42 last updated Mon Apr 12 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Aprea Therapeutics.
There is no upcoming split for Aprea Therapeutics.